Stentrode is the only implantable brain-computer interface that does not require open brain surgery and is currently in clinical trials SAN FRANCISCO & NEW YORK & MELBOURNE, Australia--(BUSINESS WIRE) ...

NEW YORK--(BUSINESS WIRE)--Synchron, a leader in non-surgical brain-computer interface (BCI) technology, announced today it has raised a $200 million Series D financing round. The funding will ...

A photo taken on August 3, 2023 shows Rodney Gorham, a recipient of a Synchron brain implant, working on a computer at his home in Melbourne. WILLIAM WEST/Getty Images Synchron, the brain-computer ...

Neuralink, Synchron, and Neuracle are expanding clinical trials and trying to zero in on an actual product. Tech companies are always trying out new ways for people to interact with computers—consider ...

Please provide your email address to receive an email when new articles are posted on . The Stentrode brain-computer interface offers a non-invasive, nonsurgical solution for paralysis. Additional ...

Apple is in the early stages of developing brain-computer interfaces that would allow people, especially those with mobility issues, to control their iPhones, iPads, and Vision Pro headsets with ...

The brain-computer interface developer Synchron has shown that its minimally invasive device can help connect a patient with an iPad, allowing them to control the device entirely by thought using ...

Synchron, a New York, NY-based manufacturer of non-surgical brain-computer interface technology, said it has raised a $200 million series D round. The funds are expected to accelerate ...

New York-based Synchron, a brain-computer interface (BCI) company, has raised $200 million in Series D funding, bringing its total raise to $345 million. Double Point Ventures led the round, with ...

Synchron has reeled in another $200 million in a series D round—cash the company said it will use to expand operations and accelerate commercialization of its nonsurgical brain-computer interface (BCI ...